Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Turk J Med Sci ; 46(3): 719-26, 2016 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-27513247

RESUMEN

BACKGROUND/AIM: India has 63 million diabetic people and the overall prevalence of diabetes in this country is 8.37%. Lifestyle modification by education is the most cost-effective strategy to have better metabolic control. The aim of this study was to investigate the effects of a self-management educational program on control of type 2 diabetes. MATERIALS AND METHODS: It was a randomized controlled interventional study conducted among 306 patients with type 2 diabetes mellitus attending the Diabetic Clinic at G.T.B. Hospital, Delhi, from March 2010 to May 2013. The intervention was in the form of group education based on a self-management program, which was earlier developed in the pilot study. RESULTS: The baseline characteristics were comparable in the two groups. After 6 months, there was a significant improvement in the HbA1c levels (P = 0.0001), physical activity level (P = 0.001), and BMI (P = 0.001) in the study group as compared to the control group and this difference persisted even when analysis was done using generalized estimation equations. CONCLUSION: The findings of this study proved that a self-management educational program is an essential component in the management of diabetes and provided concrete evidence that this is an effective instrument in the control of body weight, blood pressure, and glycated Hb levels in type 2 diabetes.


Asunto(s)
Diabetes Mellitus Tipo 2 , Automanejo , Hemoglobina Glucada , Humanos , India , Educación del Paciente como Asunto , Proyectos Piloto , Autocuidado
2.
Asian Pac J Cancer Prev ; 13(12): 6011-6, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23464395

RESUMEN

INTRODUCTION: Epidemiological studies suggest a protective role for ß-carotene with several malignancies. Esophageal adenocarcinoma frequently arises from Barrett's esophagus (BE). We postulated that ß-carotene therapy maybe protective in BE. MATERIALS AND METHOD: We conducted a prospective study in which 25 mg of ß-carotene was administered daily for six-months to six patients. Each patient underwent upper endoscopy before and after therapy and multiple mucosal biopsies were obtained. Additionally, patients completed a gastroesophageal reflux disease (GERD) symptoms questionnaire before and after therapy and severity score was calculated. To study the effect of ß-carotene at molecular level, tissue extracts of the esophageal mucosal biopsy were subjected to assessment of heat-shock protein 70 (HSP70). RESULTS: A significant (p<0.05) reduction in mean GERD symptoms severity score from 7.0±2.4 to 2.7±1.7 following ß-carotene therapy was noted. Measurement of Barrett's segment also revealed a significant reduction in mean length after therapy. In fact, two patients had complete disappearance of intestinal metaplasia. Furthermore, marked enhancement of HSP70 expression was demonstrated in biopsy specimens from Barrett's epithelium in four cases that were tested. CONCLUSIONS: Long- term ß-carotene therapy realizes amelioration of GERD symptoms along with restitution of the histological and molecular changes in esophageal mucosa of patients with BE, associated with concurrent increase in mucosal HSP70 expression.


Asunto(s)
Esófago de Barrett , beta Caroteno , Esófago , Reflujo Gastroesofágico , Proteínas HSP70 de Choque Térmico , Humanos , Estudios Prospectivos
3.
J Gastroenterol Hepatol ; 23(11): 1710-5, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18761556

RESUMEN

BACKGROUND AND AIM: The risk of acquiring hepatitis B virus (HBV) infection through exposure to blood or its products is highest amongst health care workers (HCWs). Despite potential risks, a proportion of HCWs never get vaccinated. India is second to China in the numbers of people with chronic HBV. This study aimed to investigate the vaccination practices and the prevalence of HBV infection in HCWs in India. METHODS: A total of 2162 HCWs were screened for the presence of serological markers of HBV and hepatitis C virus (HCV). Occult HBV infection was tested by detection of HBV-DNA for surface and core regions by nested polymerase chain reaction in HBsAg-negative and IgG anti-hepatitis core antigen-positive subjects. RESULTS: Only 1198 (55.4%) of the 2162 HCWs screened had been vaccinated; and 964 (44.6%) were not vaccination-status conscious; of these HCWs, 600 (27.7%) had never been vaccinated and 364 (16.4%) were unaware of their vaccination status. Protective (> 10 IU/mL) anti-hepatitis B surface (anti-HBs) antigen titers were seen in only 61.7%. The anti-HBs titers were found to be lower with the passage of time; the median anti-HBs titers in subjects who were vaccinated > 10 years ago were significantly lower than those who had been vaccinated < 5 years ago (P < 0.001). One percent of HCWs were HBsAg-positive, and 24.7% of 700 HCWs screened had past exposure (IgG-anti-HBc-positive). Occult HBV was detected in 5% of 120 positive subjects with past exposure; all had anti-HBs titers > 10 IU/mL. CONCLUSIONS: Even today, 28% HCWs in India are unvaccinated and 17% are unaware of their vaccination status. This data suggests that use of hepatitis B immune globulin be mandatory in needle-pricked HCWs in India, and that implementation of awareness strategies is urgent. Since the anti-HBs titers decline in a fair proportion, there is justification for giving a booster dose of vaccine 10 years after primary vaccination to HCWs in India.


Asunto(s)
Concienciación , Conocimientos, Actitudes y Práctica en Salud , Vacunas contra Hepatitis B , Hepatitis B/prevención & control , Esquemas de Inmunización , Cuerpo Médico de Hospitales , Enfermedades Profesionales/prevención & control , Exposición Profesional , Adulto , Actitud del Personal de Salud , ADN Viral/sangre , Femenino , Política de Salud , Hepacivirus/genética , Hepacivirus/inmunología , Hepatitis B/diagnóstico , Hepatitis B/epidemiología , Hepatitis B/transmisión , Anticuerpos contra la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/inmunología , Hepatitis C/diagnóstico , Hepatitis C/prevención & control , Anticuerpos contra la Hepatitis C/sangre , Hospitales , Humanos , India/epidemiología , Masculino , Persona de Mediana Edad , Enfermedades Profesionales/epidemiología , Prevalencia , ARN Viral/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA